OnabotulinumtoxinA treatment for neurogenic detrusor overactivity and the prevention of autonomic dysreflexia following spinal cord injury

OnabotulinumtoxinA treatment for neurogenic detrusor overactivity and the prevention of autonomic dysreflexia following spinal cord injury

Individuals with high-level (>T₆) spinal cord injury (SCI) are prone to the development of a dangerous episodic hypertensive condition called autonomic dysreflexia (AD). The urinary bladder is the number one trigger of AD and is attributed to a condition called neurogenic detrusor overactivity (N...

Full description

Bibliographic Details
Main Author:	Fougere, Renée Julia
Language:	English
Published:	University of British Columbia 2014
Online Access:	http://hdl.handle.net/2429/50192

Similar Items

Therapeutic outcome and patient adherence to repeated onabotulinumtoxinA detrusor injections in chronic spinal cord-injured patients and neurogenic detrusor overactivity
by: Sheng-Fu Chen, et al.
Published: (2015-07-01)

OnabotulinumtoxinA for neurogenic detrusor overactivity and dose differences: a systematic review
by: Rui Zhang, et al.
Published: (2015-04-01)

Efficacy and Safety of OnabotulinumtoxinA in Patients With Neurogenic Detrusor Overactivity Caused by Spinal Cord Injury: A Systematic Review and Meta-analysis
by: Guang-Ping Li, et al.
Published: (2018-12-01)

Single onabotulinumtoxinA 200U dose improved clinical symptoms but not urothelial dysfunction in neurogenic detrusor overactivity due to spinal cord injury
by: Sheng-Fu Chen, et al.
Published: (2019-01-01)

Efficacy and Safety of OnabotulinumtoxinA in Treating Neurogenic Detrusor Overactivity: A Systematic Review and Meta-analysis
by: Xin Zhou, et al.
Published: (2015-01-01)

Efficacy and Adverse Events Associated With Use of OnabotulinumtoxinA for Treatment of Neurogenic Detrusor Overactivity: A Meta-Analysis
by: Hejia Yuan, et al.
Published: (2017-03-01)

Inosine Improves Neurogenic Detrusor Overactivity following Spinal Cord Injury.
by: Yeun Goo Chung, et al.
Published: (2015-01-01)

OnabotulinumtoxinA versus IncobotulinumtoxinA in the treatment of patients with idiopathic or neurogenic detrusor overactivity: A prospective, randomized study
by: A.G. Giannantoni, et al.
Published: (2020-07-01)

Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
by: Tao Cheng, et al.
Published: (2016-01-01)

The effect of spinal cord-injury level on the outcome of neurogenic bladder treatment using OnabotulinumtoxinA
by: Waleed Al Taweel, et al.
Published: (2015-01-01)

OnabotulinumtoxinA for the treatment of overactive bladder
by: Cox L, et al.
Published: (2014-07-01)

OnabotulinumtoxinA in the treatment of neurogenic bladder
by: Gulamhusein A, et al.
Published: (2012-08-01)

A Korean Postmarketing Study Assessing the Effectiveness of OnabotulinumtoxinA for the Treatment of Neurogenic Detrusor Overactivity or Idiopathic Overactive Bladder Using a Validated Patient-Reported Outcome Measure
by: Kwang Jin Ko, et al.
Published: (2019-03-01)

Management of Neurogenic Detrusor Overactivity Caused by Spinal Cord Injury - The Case of Botulinum Toxin and Resiniferatoxin
by: Raquel Leal Monteiro Mano de Oliveira
Published: (2020)

Botulinum toxin A in the treatment of spinal cord injury patients with refractory neurogenic detrusor overactivity
by: Ronaldo A. Alvares, et al.
Published: (2010-12-01)

Intradetrusor onabotulinumtoxinA injections are significantly more efficacious than oral oxybutynin for treatment of neurogenic detrusor overactivity: results of a randomized, controlled, 24-week trial
by: Rúiter Silva Ferreira, et al.

Autonomic dysreflexia: a cardiovascular disorder following spinal cord injury
by: Hisham Sharif, et al.
Published: (2017-01-01)

Long-term response of different Botulinum toxins in refractory neurogenic detrusor overactivity due to spinal cord injury
by: Giuseppe Lombardi, et al.

Botulinum Toxin in Neurogenic Detrusor Overactivity
by: Carlos Arturo Levi D'Ancona, et al.
Published: (2012-09-01)

Effect of Memantine on Overactive Detrusor in Rats With Spinal Cord Injury
by: Cüneyd Özkürkçügil, et al.
Published: (2010-05-01)

New developments in the management of overactive bladder: focus on mirabegron and onabotulinumtoxinA
by: Andersson KE
Published: (2013-04-01)

Spinal Cord Injury and Autonomic Dysreflexia- A Case Report
by: Apurva Bhatt, et al.
Published: (2016-10-01)

Efficacy and Safety of Intravesical OnabotulinumtoxinA Injection in Patients with Detrusor Hyperactivity and Impaired Contractility
by: Chung-Cheng Wang, et al.
Published: (2016-03-01)

von Brunn's Nests and Follicular Cystitis Following Intradetrusor OnabotulinumtoxinA Injections for Overactive Bladder
by: Silpa Nekkanti, et al.
Published: (2017-09-01)

Intravesical OnabotulinumtoxinA Injection for Overactive Orthotopic Ileal Neobladder: Feasibility and Efficacy
by: Nathan Hoag, et al.
Published: (2016-03-01)

Idiopathic overactive bladder syndrome : pathophysiology and biomarkers and the therapeutic mechanism of OnabotulinumtoxinA
by: LIU, HSIN-TZU, et al.
Published: (2017)

Molecular mechanisms involved in neurogenic detrusor overactivity
by: João Paulo Garrido Vieira dos Santos
Published: (2019)

Prevalence of Autonomic Dysreflexia in Patients with Spinal Cord Injury above T6
by: Eun Sun Lee, et al.
Published: (2017-01-01)

Early Fesoterodine Fumarate Administration Prevents Neurogenic Detrusor Overactivity in a Spinal Cord Transected Rat Model.
by: Xavier Biardeau, et al.
Published: (2017-01-01)

Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity
by: Stacey Tannenbaum, et al.
Published: (2020-12-01)

Factors Associated with Therapeutic Efficacy of Intravesical OnabotulinumtoxinA Injection for Overactive Bladder Syndrome.
by: Sheng-Mou Hsiao, et al.
Published: (2016-01-01)

Estudo comparativo entre cloridrato de oxibutinina e onabotulinumtoxina em pacientes portadores de lesão medular com hiperatividade do detrusor = avaliação urodinâmica e qualidade de vida = Comparative study between oxybutynin chloride and onabotulinumtoxinA in spinal cord injured patients with detrusor overactivity urodynamic evaluation and quality of life
by: Ferreira, Rúiter Silva, 1967-
Published: (2012)

Crusted scabies triggering autonomic dysreflexia in a patient with spinal cord injury
by: Delila Pouldar Foulad, MD, et al.
Published: (2020-07-01)

Molecular and functional characterization of detrusor PDGFRα positive cells in spinal cord injury-induced detrusor overactivity
by: Ken Lee, et al.
Published: (2021-08-01)

Effects of early exercise training on the severity of autonomic dysreflexia following incomplete spinal cord injury in rodents
by: Kathryn A. Harman, et al.
Published: (2021-08-01)

Plasticity of TRPV1-expressing sensory neurons mediating autonomic dysreflexia following spinal cord injury
by: Leanne M Ramer, et al.
Published: (2012-07-01)

Experience of onabotulinumtoxinA (Botox) treatment for overactive bladder in outpatient clinic with less number of injections
by: A.K. Habib, et al.
Published: (2020-07-01)

Cost-Utility Analysis of Oxybutynin vs. OnabotulinumtoxinA (Botox) in the Treatment of Overactive Bladder Syndrome
by: Habiba Shabir, et al.
Published: (2021-08-01)

TARGETING MALADAPTIVE PLASTICITY AFTER SPINAL CORD INJURY TO PREVENT THE DEVELOPMENT OF AUTONOMIC DYSREFLEXIA
by: Eldahan, Khalid C.
Published: (2019)

Intraspinal Plasticity Associated With the Development of Autonomic Dysreflexia After Complete Spinal Cord Injury
by: Felicia M. Michael, et al.
Published: (2019-11-01)